Franco Cavalli

1978–2024 年に発表

66
論文数
21,601
被引用数
60
h 指数
65
i10 指数

被引用数

Franco Cavalli の年別被引用数1979 年: 被引用 2 件1980 年: 被引用 1 件1982 年: 被引用 3 件1983 年: 被引用 1 件1984 年: 被引用 3 件1985 年: 被引用 3 件1987 年: 被引用 1 件1988 年: 被引用 1 件1989 年: 被引用 2 件1990 年: 被引用 5 件1991 年: 被引用 4 件1992 年: 被引用 2 件1994 年: 被引用 1 件1995 年: 被引用 7 件1996 年: 被引用 15 件1997 年: 被引用 25 件1998 年: 被引用 24 件1999 年: 被引用 8 件2000 年: 被引用 26 件2001 年: 被引用 37 件2002 年: 被引用 31 件2003 年: 被引用 52 件2004 年: 被引用 51 件2005 年: 被引用 82 件2006 年: 被引用 105 件2007 年: 被引用 71 件2008 年: 被引用 88 件2009 年: 被引用 83 件2010 年: 被引用 88 件2011 年: 被引用 64 件2012 年: 被引用 76 件2013 年: 被引用 92 件2014 年: 被引用 67 件2015 年: 被引用 91 件2016 年: 被引用 124 件2017 年: 被引用 138 件2018 年: 被引用 120 件2019 年: 被引用 537 件2020 年: 被引用 577 件2021 年: 被引用 602 件2022 年: 被引用 522 件2023 年: 被引用 348 件2024 年: 被引用 594 件2025 年: 被引用 255 件2026 年: 被引用 6 件1981 年は被引用が無いため表示していません1986 年は被引用が無いため表示していません1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,677 件、この内訳の 19.6%イタリア: 引用元論文 614 件、この内訳の 7.2%イギリス: 引用元論文 587 件、この内訳の 6.9%ドイツ: 引用元論文 542 件、この内訳の 6.3%中国: 引用元論文 531 件、この内訳の 6.2%フランス: 引用元論文 520 件、この内訳の 6.1%スイス: 引用元論文 351 件、この内訳の 4.1%スペイン: 引用元論文 343 件、この内訳の 4%カナダ: 引用元論文 303 件、この内訳の 3.5%オーストラリア: 引用元論文 272 件、この内訳の 3.2%オランダ: 引用元論文 272 件、この内訳の 3.2%日本: 引用元論文 184 件、この内訳の 2.2%
0%19.6%その他 27.5%

分野

  • Medicine86.2%
  • Biochemistry, Genetics and Molecular Biology7.8%
  • Immunology and Microbiology3.5%
  • Health Professions0.4%
  • Computer Science0.3%
  • Economics, Econometrics and Finance0.3%
  • その他1.5%

トピック

  • Lymphoma Diagnosis and Treatment20.3%
  • CNS Lymphoma Diagnosis and Treatment8.2%
  • CAR-T cell therapy research5.8%
  • Chronic Lymphocytic Leukemia Research4.5%
  • Viral-associated cancers and disorders4.4%
  • Glioma Diagnosis and Treatment2.4%
  • その他54.4%

共著者

全論文

検索で開く
  1. Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

    著者: , , , , , , - Journal of Clinical Oncology 2014 被引用: 5,552

  2. Non-Hodgkin lymphoma

    著者: , , , - The Lancet 2017 被引用: 1,176

  3. Encouraging AWaRe-ness and discouraging inappropriate antibiotic use—the new 2019 Essential Medicines List becomes a global antibiotic stewardship tool

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2019 被引用: 255

  4. Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2005 被引用: 906

  5. Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Franco Cavalli, Emanuele Zucca, Luigi Maria Larocca, Gianluca Gaïdano, Stefan Hohaus, Carmelo Carlo‐Stella, Davide Rossi - Blood 2018 被引用: 338

  6. Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alessandro Levis, Hans‐Joachim Schmoll, Franco Cavalli, Jürgen Finke, Michele Reni, Emanuele Zucca, Gerald Illerhaus - The Lancet Haematology 2016 被引用: 599

  7. Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bernd Hertenstein, Mathias Rummel, Jeffery Smith, Lorenz Thurner, Giuseppina Cabras, Elsa Pennese, Maurilio Ponzoni, Martina Deckert, Letterio S. Politi, Jürgen Finke, Antonella Ferranti, Kelly Cozens, Elvira Burger, Nicoletta Ielmini, Franco Cavalli, Emanuele Zucca, Gerald Illerhaus, IELSG32 study investigators - Leukemia 2022 被引用: 162

  8. Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bernd Hertenstein, Mathias Rummel, Jeffery Smith, Michael Pfreundschuh, Giuseppina Cabras, F. Angrilli, Maurilio Ponzoni, Martina Deckert, Letterio S. Politi, Jürgen Finke, Michele Reni, Franco Cavalli, Emanuele Zucca, Gerald Illerhaus - The Lancet Haematology 2017 被引用: 381

  9. Prognostic Scoring System for Primary CNS Lymphomas: The International Extranodal Lymphoma Study Group Experience

    著者: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2003 被引用: 840

  10. European Code against Cancer 4th Edition: 12 ways to reduce your cancer risk

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marie‐Christine Boutron‐Ruault, Michele Cecchini, Tim Key, Michael F. Leitzmann, Teresa Norat, Hilary J. Powers, Chiara Scoccianti, Anssi Auvinen, Esther de Vries, Friederike Erdmann, Rüdiger Greinert, John Harrison, Ausrele Kesminiene, Neil McColl, Søren Friis, Manolis Kogevinas, Rodolfo Saracci, Kurt Straif, Harri Vainio, Maribel Almonte, Ahti Anttila, Hugo De Vuyst, Joakim Dillner, Silvia Franceschi, Paula González, Andrew Hall, Jin Young Park, Paola Armaroli, Wendy Atkin, Peter B. Dean, Harry J. de Koning, Lena Dillner, Ernst J. Kuipers, Iris Lansdorp‐Vogelaar, Euǵenio Paci, Jarosław Reguła, Eero Suonio, Sven Törnberg, Lynn F. Wood, Nicolas Gaudin, Kirstin Grosse Frie, Veronique Terrasse, Kelly Winstanley, Cristina Bellisario, Elena Biagioli, Michela Cinquini, Silvia Gianola, Marien Gonzalez Lorenzo, Lawrence von Karsa, Tracy Lignini - Cancer Epidemiology 2015 被引用: 281

  11. Genetic and phenotypic attributes of splenic marginal zone lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Enrico Derenzini, Liliana Devizzi, Sascha Dietrich, Angela Rita Elia, Fabio Facchetti, Gianluca Gaïdano, Juan F. Garcı́a, B. Gerber, Paolo Ghia, María Gomes da Silva, Giuseppe Gritti, Anna Guidetti, Felicitas Hitz, Giorgio Inghirami, Marco Ladetto, Armando López‐Guillermo, Elisa Lucchini, Antonino Maiorana, Roberto Marasca, Estella Matutes, Véronique Meignin, Michele Merli, Alden A. Moccia, Manuela Mollejo, Carlos Montalbán, Urban Novak, David Oscier, Francesco Passamonti, Francesco Piazza, Stefano Pizzolitto, Alessandro Rambaldi, Elena Sabattini, Gilles Salles, Elisa Santambrogio, Lydia Scarfò, Anastasios Stathis, Georg Stüssi, Julia T. Geyer, Gustavo Tapia, Corrado Tarella, Catherine Thiéblemont, Thomas Tousseyn, Alessandra Tucci, Giorgio Vanini, Carlo Visco, Umberto Vitolo, Renata Walewska, Francesco Zaja, Thorsten Zenz, Pier Luigi Zinzani, Hossein Khiabanian, Arianna Calcinotto, Francesco Bertoni, Govind Bhagat, Elı́as Campo, Laurence de Leval, Stefan Dirnhofer, Stefano Pileri, Miguel Á. Piris, Alexandra Traverse‐Glehen, Alexandar Tzankov, Marco Paulli, Maurilio Ponzoni, Luca Mazzucchelli, Franco Cavalli, Emanuele Zucca, Davide Rossi - Blood 2021 被引用: 97

  12. Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma

    著者: , , , , , , , , , , , , , , , , , , , - Blood 2015 被引用: 176

  13. Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma

    著者: , , , , , , , , , , , , , , , - Blood 2018 被引用: 111

  14. High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Federico Caligaris‐Cappio, Franco Cavalli - The Lancet 2009 被引用: 662

  15. Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’1

    著者: , , , , , , , , , , , , , , , , , , , , - British Journal of Haematology 2004 被引用: 610

  16. International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tycho Baumann, Antonino Neri, Manlio Ferrarini, Richard Rosenquist, Francesco Forconi, Robin Foà, Šárka Pospı́šilová, Fortunato Morabito, Stephan Stilgenbauer, Hartmut Döhner, Sameer A. Parikh, William G. Wierda, Emili Montserrat, Gianluca Gaïdano, Michael Hallek, Davide Rossi - Blood 2020 被引用: 139

  17. Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters support: a descriptive study

    著者: , , , , , , , , , , , - The Lancet Oncology 2008 被引用: 266

  18. Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ashis Mukhopadhyay, Balkis Meddeb, Bernard De Prijck, Bernardo Garichochea, Bülent Ündar, Caballero Gabarrón, Carmen Cao, Cármino Antônio De Souza, Charles M. Farber, Cheol Won Suh, C Burcoveanu, C. Cebotaru, Cristina-Ligia Truica, Dai Maruyama, David Belada, Dina Ben Yehuda, Dmitry Udovitsa, Dolores, Enrica Morra, E. Späth‐Schwalbe, Eva González‐Barca, Evgenii A. Osmanov, Francisco Capote, Fritz Offner, Gálvez Cárdenas, Georg Heß, Georgii Manikhas, Govind Babu, Grigoriy Rekhtman, Guiseppe Rossi, Herlander Marques, Horia Bumbea, Huaqing Wang, Huiqiang Huang, Ilseung Choi, Irina Bulavina, Irina B. Lysenko, Irit Avivi, Iryna Kryachok, Jan Maciej Zaucha, Jan Novák, Joaquín Díaz, Judit Demeter, Julia Alexeeva, Jun Zhu, Kateryna Vilchevskaya, Kenichi Ishizawa, Kenny Mauricio, Kensei Tobinai, Kiyoshi Ando, Kudrat Abdulkadryrov, Lee‐Yung Shih, Lyudmila Kuzina, Mahmut Gümüş, Maike de Wit, Marcelo Capra, Margarida Marques, Marina Golubeva, Mario Ojeda‐Uribe, Maryna Kyselyova, Masafumi Taniwaki, Massimo Federico, Michael Crump, Michele Baccarani, Michinori Ogura, Miklós Egyed, M. Udvardy, Mitsutoshi Kurosawa, Naokuni Uike, Nuriet K. Khuageva ほか 43 名 - The Lancet Oncology 2018 被引用: 140

  19. Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pieter Sonneveld, Carrie A. Thompson, Kyriaki Tzogani, Flora E. van Leeuwen, Galina Velikova, Diego Villa, John R. Wingard, Sophie Wintrich, John F. Seymour, Thomas M. Habermann - The Lancet Haematology 2018 被引用: 133

  20. Definition, Diagnosis, and Management of Intravascular Large B-Cell Lymphoma: Proposals and Perspectives From an International Consensus Meeting

    著者: , , , , , , , , , , , - Journal of Clinical Oncology 2007 被引用: 484

  21. First-Line Treatment for Primary Testicular Diffuse Large B-Cell Lymphoma With Rituximab-CHOP, CNS Prophylaxis, and Contralateral Testis Irradiation: Final Results of an International Phase II Trial

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2011 被引用: 239

  22. Histologic transformation in marginal zone lymphomas

    著者: , , , , , , , , , , , - Annals of Oncology 2015 被引用: 125

  23. Incidence, risk factors and outcome of histological transformation in follicular lymphoma

    著者: , , , , , , , , , , , - British Journal of Haematology 2012 被引用: 109

  24. Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma

    著者: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 被引用: 385